BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16818627)

  • 1. Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia.
    Polley AC; Mulholland F; Pin C; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
    Cancer Res; 2006 Jul; 66(13):6553-62. PubMed ID: 16818627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis.
    Alfonso P; Núñez A; Madoz-Gurpide J; Lombardia L; Sánchez L; Casal JI
    Proteomics; 2005 Jul; 5(10):2602-11. PubMed ID: 15924290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
    Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
    J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential protein markers for nutritional health effects on colorectal cancer in the mouse as revealed by proteomics analysis.
    Breikers G; van Breda SG; Bouwman FG; van Herwijnen MH; Renes J; Mariman EC; Kleinjans JC; van Delft JH
    Proteomics; 2006 May; 6(9):2844-52. PubMed ID: 16596712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay.
    Guadagni F; Roselli M; Cosimelli M; Spila A; Cavaliere F; Tedesco M; Arcuri R; Abbolito MR; Casale V; Pericoli MN; Vecchione A; Casciani CU; Greiner JW; Schlom J
    Cancer Res; 1996 Nov; 56(22):5293-8. PubMed ID: 8912871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer.
    Roesch-Ely M; Nees M; Karsai S; Ruess A; Bogumil R; Warnken U; Schnölzer M; Dietz A; Plinkert PK; Hofele C; Bosch FX
    Oncogene; 2007 Jan; 26(1):54-64. PubMed ID: 16819514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of colonic polyps by two-dimensional gel electrophoresis.
    Melis R; White R
    Electrophoresis; 1999; 20(4-5):1055-64. PubMed ID: 10344285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preoperative molecular staging of colorectal cancers by CM10 ProteinChip and SELDI-TOF-MS analysis].
    Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):753-7. PubMed ID: 17366787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proteome study of colorectal cancer genesis and hepatic metastasis].
    An P; Yu B; Li SY; Zhang YN; Cai HY
    Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):668-71. PubMed ID: 15329256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA adducts in normal colonic mucosa from healthy controls and patients with colon polyps and colorectal carcinomas.
    Jonsson C; Stål P; Sjöqvist U; Akerlund JE; Löfberg R; Möller L
    Mutagenesis; 2010 Sep; 25(5):499-504. PubMed ID: 20551081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of in situ proteomic profiling and implications for study design in colorectal tumors.
    Li JQ; Xu BJ; Shakhtour B; Deane N; Merchant N; Heslin MJ; Washington K; Coffey RJ; Beauchamp RD; Shyr Y; Billheimer D
    Int J Oncol; 2007 Jul; 31(1):103-11. PubMed ID: 17549410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of reduced folate carrier-1 and folylpolyglutamate synthase correlates with lack of a deleted in colorectal carcinoma mRNA splice variant in normal-appearing mucosa of colorectal carcinoma patients.
    Wettergren Y; Odin E; Nilsson S; Willen R; Carlsson G; Gustavsson B
    Cancer Detect Prev; 2005; 29(4):348-55. PubMed ID: 16122883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proteome study of colorectal cancer genesis and hepatic metastasis].
    Bai X; Li SY; An P; Yu B; Cai HY
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2128-31. PubMed ID: 16313824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of distinctive protein expression patterns in colorectal adenoma.
    F Lam F; Jankova L; Dent OF; Molloy MP; Kwun SY; Clarke C; Chapuis P; Robertson G; Beale P; Clarke S; Bokey EL; Chan C
    Proteomics Clin Appl; 2010 Jan; 4(1):60-70. PubMed ID: 21137016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival.
    Kim H; Kang HJ; You KT; Kim SH; Lee KY; Kim TI; Kim C; Song SY; Kim HJ; Lee C; Kim H
    Proteomics; 2006 Jun; 6(11):3466-76. PubMed ID: 16645984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ProteinChip Array analysis of microdissected colorectal carcinoma and associated tumor stroma shows specific protein bands in the 3.4 to 3.6 kDa range.
    Krieg RC; Fogt F; Braunschweig T; Herrmann PC; Wollscheidt V; Wellmann A
    Anticancer Res; 2004; 24(3a):1791-6. PubMed ID: 15274357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of hydrophobic proteins as biomarker candidates for colorectal cancer.
    Alvarez-Chaver P; Rodríguez-Piñeiro AM; Rodríguez-Berrocal FJ; Martínez-Zorzano VS; Páez de la Cadena M
    Int J Biochem Cell Biol; 2007; 39(3):529-40. PubMed ID: 17084656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: the S100A9 and S100A8 positive cells underlie and invade tumor mass.
    Stulík J; Osterreicher J; Koupilová K; Knízek ; Macela A; Bures J; Jandík P; Langr F; Dedic K; Jungblut PR
    Electrophoresis; 1999; 20(4-5):1047-54. PubMed ID: 10344284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-dimensional electrophoretic study of normal colon mucosa and colorectal cancer.
    Kovarova H; Stulík J; Hochstrasser DF; Bures J; Melichar B; Jandík P
    Appl Theor Electrophor; 1994; 4(3):103-6. PubMed ID: 7612691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.